Fizer Pharmaceutical paid $68 maltion on January 2, 2024, for 4 million shares of Carne Cosmetics common stock. The investment. represents a 25% interest in the net assets of Came and gave Fizet the ability to exercise sinnificant influence over Carne's operations Fizet received dividends of $1 per share on December 21,2024 , and Came reported net income of $40 million for the year ended December 31,2024. The fair value of Carne's common stock at December 31, 2024, was $18.50 per share. - The book value of Came's net assets was $192 million. - The fair value of Carne's depreclable assets exceeded their book value by $32 million. These ossets had an average remaining useful life of eight years. - The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill. Required: Complete the table below and prepare the appropriate joumal entries related to the investment during 2024 Answer is not complete. Complete this question by entering your inswers th the tabs below. Prepare the appropriate fournal entries related to the investment durina 2024 Note: If no entry is required for a transaction/event, select "No fournal entry is wuired" in the first account fleld. Enter your answers in milions, (Le, 10,000,000 shoufd be enteted as 10). Required: Complete the table below and prepare the appropriate joumal entries related to the investment during 2024. Complete this question by entering your answers in the tabs below. Complete the table below. Complete the table below. Note: Enter your answers in millions, (1.e., 10,000,000 should be entered as 10). Record the investment in Carne Cosmetics shares. Record the investor's share of net income. Record the cash dividends. 4 Record the depreciation adjustment. 5 Record the fair value adjustment at year-end